This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Nebius Group stunned investors with a strong May, signaling momentum in its AI cloud push. This guide breaks down wha...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
The IPO market is warming up, and financial stocks could ride the wave. Explore who stands to gain, how underwriting ...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
Investors weigh a massive AI financing move and its impact on a major server maker’s backlog. This piece explains wha...
Gold prices lure investors to miners as a way to gain leveraged exposure to gold. This article compares two different...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Canada's online brokerage scene is evolving as fee cuts and wider cross-border access reshape investor options. Here ...
Solar energy is surpassing coal in grid contributions, signaling a pivotal shift for investors. Explore three dividen...
A thoughtful, real-world guide to deciding whether to buy Amazon before July earnings. Learn how to weigh growth driv...
As March 2026 brings renewed market volatility, investors are weighing public alternatives to Public.com. This report...